Cart is empty Former U.S. Surgeon General Dr. Vivek Murthy is urging lawmakers to take stronger steps to protect children from the potential dangers of social media.
Integrating pharmacogenomic guided prescribing into routine clinical practice
Pharmacogenomics studies how individuals respond to drugs based on their genetic code. Using that knowledge to guide prescribing in routine care could lead to better outcomes for patients and save money for health systems.
Targeting the epipharynx to disrupt the residual triggers of COVID-19 in patients with long COVID
The COVID-19 pandemic had a profound effect on the world, resulting in a dramatic loss of human lives. While the situation is now largely under control, there are patients who still suffer from the disease and have symptoms lasting for more than three months. The set of these symptoms has been linked to a condition called “long COVID,” which persists after an initial period of COVID-19 infection. While the condition is still under study, researchers in Japan have made a significant discovery in the fight against long COVID.
Attaching fluorescing dye to oral cancer proteins could yield powerful prediction tool for varying cancer types
Some 10 million people in the U.S. have oral premalignant disease, a group of diseases that show up as red patches, white patches or rough patches in the mouth and that might—or might not—develop into cancer.
Aussies support government action on sugary and sweetened drinks to tackle obesity
Public health experts are urging the new Albanese Government to prioritize tackling obesity, with new research showing widespread public support for the implementation of strong measures to curb the consumption of sugary and sweetened beverages.
NIH director’s COVID comments spark staff walkout
Dozens of staff at the U.S. National Institutes of Health (NIH) walked out of a recent town hall meeting after Director Dr. Jay Bhattacharya suggested the agency may have helped fund research that caused the COVID-19 pandemic.
Sugar consumed through soda, fruit juice consistently linked to higher risk of developing type 2 diabetes
For years, we’ve been told that sugar is a major culprit behind the global rise in type 2 diabetes. Now, emerging evidence from BYU researchers adds nuance to that message, suggesting that not all sugar sources carry the same risk.
New online tool predicts risk of energy deficiency in young, exercising women
Many female athletes and physically active women fail to consume enough energy to meet their bodies’ needs, jeopardizing their reproductive and bone health and athletic performance, according to prior studies by researchers at Penn State and elsewhere. Measuring energy deficiency can be a barrier to understanding the problem, however, because it requires extensive laboratory testing or invasive blood collection.
Maintenance lurbinectedin + atezolizumab enhances survival in lung cancer
Maintenance therapy with lurbinectedin (lurbi) and atezolizumab (atezo) helps some patients with extensive-stage small cell lung cancer (ES-SCLC) live longer versus maintenance therapy with atezolizumab alone, according to a study presented at the annual meeting of the American Society of Clinical Oncology, held from May 31 to June 4 in Chicago.
Combining stem cell engineering and drug therapy to suppress abnormal bone formation
A research team led by Associate Professor Makoto Ikeya in the Department of Clinical Application at Kyoto University has developed a promising new therapeutic strategy for fibrodysplasia ossificans progressiva (FOP)—a rare and severely disabling genetic disorder—by combining low-dose rapamycin with mesenchymal stem/stromal cells (MSCs) derived from induced pluripotent stem (iPS) cells. The paper is published in the journal JBMR Plus.